TB500 Peptide | MendStride

Peptide Therapy

TB-500 is a synthetic peptide related to the actin-binding peptide thymosin beta-4 and is studied mainly in preclinical repair and angiogenesis models.

C38H68N10O14

Synthetic Tβ4-related peptide

Preclinical repair focus

Research Only

Result Durationv

Typically 3 months

Price From

£350 per month

At A Glance

Research Only

Result Durationv

Typically 3 months

Price From

£350 per month

What Is TB500?

TB-500 is generally described as a synthetic active-region peptide related to thymosin beta-4. Most mechanistic literature concerns thymosin beta-4 itself, so direct human evidence for TB-500 is much more limited than the broader Tβ4 research base.

Research & Compound Overview Snapshot

TB-500 is usually discussed through the broader thymosin beta-4 literature, which is richer than direct TB-500 evidence.

Reviews of thymosin beta-4 describe roles in actin dynamics, angiogenesis, cell migration and regeneration. TB-500 is marketed as a related synthetic peptide, but published direct human data for TB-500 itself remain very limited.

TB-500 is best understood as a synthetic peptide related to thymosin beta-4 rather than a stand-alone, well-characterised approved drug.

Type: Synthetic peptide Structure: Tβ4-related active-region peptide Class: Regenerative / actin-signalling research peptide

The relevant literature suggests TB-500 is intended to mimic selected thymosin beta-4 activities linked to actin regulation, cell migration, angiogenesis and tissue remodelling.

Because most evidence comes from thymosin beta-4 rather than direct TB-500 trials, mechanism claims should be interpreted cautiously.

How Does TB500 Work?

Preclinical insights into TB500’s cellular signalling and growth factor pathways.

The relevant literature suggests TB-500 is intended to mimic selected thymosin beta-4 activities linked to actin regulation, cell migration, angiogenesis and tissue remodelling.

Because most evidence comes from thymosin beta-4 rather than direct TB-500 trials, mechanism claims should be interpreted cautiously.

How Does TB500 Work?

Preclinical insights into TB500’s cellular signalling and growth factor pathways.

How Peptide Treatments Help ?

Through the use of peptides, this therapy works by supporting cellular communication and natural regulatory pathways. The peptides follow pathways that already exist within the body.

Frequently Asked Questions

Key questions answered on TB500

Direct TB-500 human evidence is limited; the stronger mechanistic literature belongs to thymosin beta-4.

The relevant literature suggests TB-500 is intended to mimic selected thymosin beta-4 activities linked to actin regulation, cell migration, angiogenesis and tissue remodelling. Because most evidence comes from thymosin beta-4 rather than direct TB-500 trials, mechanism claims should be interpreted cautiously.

Published human data specific to TB-500 are sparse compared with the parent thymosin beta-4 literature.

Current discussion usually extrapolates from thymosin beta-4 biology rather than large TB-500 trials.

No. It is a synthetic peptide related to thymosin beta-4 biology, not a classic endocrine hormone.

This page is marked research only because direct TB-500 clinical evidence remains limited and indirect.

Research Overview

Consultation

A free phone call, video or in person consultation.

Treatment

Once you’ve spoken with your medical professional you’ll be given a treatment plan.

Aftercare

Your doses will be shipped or given to you to be used during the treatment plan period.

Related Peptides

Other peptides with similar characteristics

C129H215N33O55

28-aa thymic peptide

Immune-modulating literature

Thymosin Alpha Peptide

C28H48CuN12O8

Copper peptide complex

Naturally occurring tripeptide

GHK-Cu Peptide

C16H30N4O4

Lys-Pro-Val tripeptide

Alpha-MSH fragment

KPV Peptide